PCM
CBST

Penn Capital Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Penn Capital Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-103,635
Closed -$6.88M – 328
2014
Q3 		$6.88M Sell
103,635
-1,594
-2% -$105K 0.29% 119
2014
Q2 		$7.35M Sell
105,229
-2,636
-2% -$179K 0.28% 123
2014
Q1 		$7.89M Sell
107,865
-1,258
-1% -$93.8K 0.3% 116
2013
Q4 		$7.51M Sell
109,123
-63,048
-37% -$4.08M 0.27% 124
2013
Q3 		$10.9M Buy
+172,171
New +$10.4M 0.45% 81

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Penn Capital Management's CBST Position: Q4 2014 in Review

Penn Capital Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 103,635 shares — an estimated $6.88M sold.

Penn Capital Management first reported a position in CBST in Q3 2013 and held it in 5 quarters. The position peaked at $10.9M in Q3 2013. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Penn Capital Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Penn Capital Management sold 103,635 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $6.88M.
  • Penn Capital Management first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and held it in 5 quarters.
  • Penn Capital Management's CUBIST PHARMACEUTICALS INC position peaked at $10.9M in Q3 2013.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Penn Capital Management's 13F filing for Q4 2014, filed 12 Feb 2015.